RGEN – repligen corporation (US:NASDAQ)

News

Repligen (RGEN) is now covered by Roth Mkm. They set a "buy" rating and a $160.00 price target on the stock.
Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network
Repligen (RGEN) was given a new $160.00 price target by Rothschild & Co Redburn.
Repligen (RGEN) had its "overweight" rating reaffirmed by Barclays PLC.
1 Cash-Producing Stock Worth Your Attention and 2 We Avoid [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com